Novel glucose-lowering drugs for non-alcoholic fatty liver disease.

World J Diabetes · 2021 · PMC7807257 · PMID 33520110

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

marginal significanceP = 0.06so close (0.05 < p ≤ 0.1)

MRI-PDFF was observed in two studies with SGLT2 inhibitor treatment, and the results suggested that SGLT2 inhibitor treatment decreased MRI-PDFF with marginal significance in the comparison with the control group (WMD = -1.18%, 95%CI: -2.38% to 0.03%, P = 0.06) (Table 4 ).

also in 4,575 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.